Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

Upstream Processing

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID.

Viruses·2025

Same author

A Multi-Antigen Broad-Spectrum Coronavirus Vaccine Induces Potent and Durable Cross-Protection Against Infection and Disease Caused by Multiple SARS-CoV-2 Variants.

Research square·2025

Same author

A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants.

Human vaccines & immunotherapeutics·2025

Same author

Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19.

Frontiers in immunology·2025

Same author

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines.

Vaccines·2025

Same author

Dynamics of Spike-Specific Neutralizing Antibodies Across Five-Year Emerging SARS-CoV-2 Variants of Concern Reveal Conserved Epitopes that Protect Against Severe COVID-19.

bioRxiv : the preprint server for biology·2024

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Vaccine manufacturing: challenges and solutions.

Jeffrey B Ulmer¹, Ulrich Valley, Rino Rappuoli

¹Novartis Vaccines and Diagnostics, 4560 Horton St., Mailstop 4.3, Emeryville, California 94608, USA. jeffrey_ulmer@chiron.com

Nature Biotechnology

|November 10, 2006

Summary

New vaccine technologies like gene-based vaccines offer hope against shortages and infectious diseases. These innovations promise safer, more effective vaccines for faster global access, despite production costs.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Published on: April 4, 2025

Related Experiment Videos

Last Updated: Jul 19, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Published on: April 4, 2025

Area of Science:

Vaccinology
Biotechnology
Infectious Disease Prevention

Background:

Recent influenza vaccine shortages highlight vulnerabilities in global vaccine supply chains.
Manufacturing disruptions can severely limit access to essential vaccines.

Purpose of the Study:

To explore how new technologies can prevent vaccine shortages and improve vaccine access.
To identify promising technological approaches for developing advanced vaccines.

Main Methods:

Review of emerging vaccine technologies including gene-based vaccines, virus-like particles, plant-derived vaccines, novel adjuvants, and delivery systems.
Analysis of the potential impact of these technologies on vaccine discovery, assessment, development, and production.

Main Results:

New technologies offer potential solutions to vaccine supply chain vulnerabilities.
Approaches like gene-based vaccines and virus-like particles can lead to safer and more potent vaccine candidates.
These advancements could enable faster access to a wider range of effective vaccines.

Conclusions:

Technological innovation is crucial for overcoming vaccine manufacturing challenges and ensuring global vaccine security.
While promising, increased production costs and regulatory uncertainty pose challenges for the widespread adoption of new vaccine technologies.